García Amanda Coves, Pagán Emilio José Poveda
Physiotherapy Area, Department of Pathology and Surgery, Miguel Hernández University, Elche, Elche, Alicante, Spain.
Physiotherapy Department, Department of Pathology and Surgery, Miguel Hernández University, San Juan de Alicante, Alicante, Spain.
Trials. 2025 Jan 29;26(1):29. doi: 10.1186/s13063-025-08736-7.
Women's football has experienced exponential growth over the last 10 years. Its popularity is associated with an increase in ACL injuries. They constitute a major current problem as they account for 43% of the injury burden during the sports season. Despite the existing training programs, no uniform criteria have been established to design a precise intervention protocol, with specific tasks linked to women's football, nor has it been proposed to optimize the current programs.
Randomized, double-blind, single-center clinical trial protocol scheduled for the 2025-2026 women's football season. There will be 2 groups: a group that will follow a specific ACL injury prevention protocol and a control group. The intervention period will last 12 weeks. Measurements will be taken at 3 time points. The biomechanics of the lower limbs, the jump-landing dynamics, and the pre- and post-training satisfaction of the players will be evaluated. Image capture and processing systems will be used as well as tests such as the DVJ and the LESS scoring system, among others.
This protocol aims to be one of the first to implement an ACL injury prevention program for women footballers with DKV. Despite the scarcity of research in this area, studies support beneficial effects at a preventive level.
ClinicalTrials.gov NCT06083818. Registered on 03 October 2023.
在过去10年中,女子足球经历了指数级增长。其受欢迎程度与前交叉韧带(ACL)损伤的增加有关。这些损伤构成了当前的一个主要问题,因为它们占体育赛季损伤负担的43%。尽管存在现有的训练计划,但尚未建立统一的标准来设计精确的干预方案,以及与女子足球相关的特定任务,也没有人提议优化当前的计划。
计划于2025 - 2026女子足球赛季进行随机、双盲、单中心临床试验方案。将有2组:一组遵循特定的ACL损伤预防方案,另一组为对照组。干预期将持续12周。将在3个时间点进行测量。将评估下肢的生物力学、跳跃着陆动力学以及球员训练前后的满意度。将使用图像捕捉和处理系统以及诸如DVJ和LESS评分系统等测试。
该方案旨在成为首批为患有DKV的女足球运动员实施ACL损伤预防计划的方案之一。尽管该领域的研究稀缺,但研究支持在预防层面的有益效果。
ClinicalTrials.gov NCT06083818。于2023年10月3日注册。